Chimeric Therapeutics is trading at A$0.04 (+5%) today, with the move appearing to be driven by broader sector sentiment rather than a company-specific catalyst.
- The price action is consistent with the high volatility typical of low-priced ASX biotech stocks rather than a response to a fresh announcement.
- While firm sentiment across the broader biotech sector can support small-cap healthcare names, no specific macro or sector-wide event was identified as a direct driver.